Jiahe Zheng

Dr. Jiahe Zheng


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2018 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
JZJiahe Zheng
Jiahe Zheng
ZIZubin Irani
Zubin Irani
DLDonald Lawrence
Donald Lawrence
KFKeith Flaherty
Keith Flaherty
RARonald Arellano
Ronald Arellano

1 June 2019 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
YZYanhua Zhen
Yanhua Zhen
BLBin Liu
Bin Liu
ZCZhihui Chang
Zhihui Chang
HRHaiyan Ren
Haiyan Ren
ZLZhaoyu Liu
Zhaoyu Liu
JZJiahe Zheng
Jiahe Zheng
Purpose: The aim of this pooled analysis was to evaluate the clinical efficacy and safety of transarterial radioembolization (TARE) with yttrium-90 (90Y) microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma (ICC). Methods: We searched the Cochrane Library, Embase, PubMed, SCI with the English language from inception to October 2018. A pooled analysis was conducted using Stata software. Results: There were 16 eligible studies included in this pooled analysis. The pooled median overall survival (OS) from 12 studies was 14.3 (95% CI: 11.9–17.1) months. Based on Response Evaluation Criteria in Solid Tumors (RECIST), no complete response was reported, and the median of partial response, stable disease and progressive disease were 11.5% (range: 4.8–35.3%), 61.5% (range: 42.9–81.3%) and 22.7% (range: 12.5–52.4%) respectively. The pooled disease control rate (DCR) from nine studies was 77.2% (95% CI: 70.2–84.2%). According to the type of microspheres, subgroup analysis was performed, the median OS in the glass microspheres group was 14.0 (95% CI: 9.1–21.4) months, and 14.3 (95% CI: 11.5–17.8) months in the resin microspheres group. The DCR was 77.3% (95% CI: 63.5–91.1%) and 77.4% (95% CI: 66.8–87.9%) in the glass and resin microspheres groups respectively. Most of the side effects reported in the included studies were mild and did not require intervention. Conclusion: TARE with 90Y microspheres is safe and effective for patients with unresectable ICC with acceptable side effects. And it seems that the type of microsphere has no influence on therapeutic efficacy.

6 September 2024 in Atherosclerosis
Verified
Journal Article
Closed access
YZYanhua Zhen
Yanhua Zhen
JYJiaqi Yang
Jiaqi Yang
JSJi Song
Ji Song
ZXZeyu Xing
Zeyu Xing
JZJiahe Zheng
Jiahe Zheng

1 May 2021 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Open access
PDF file
HRHaiyan Ren
Haiyan Ren
YZYanhua Zhen
Yanhua Zhen
ZGZheng Gong
Zheng Gong
CWChuanzhuo Wang
Chuanzhuo Wang
ZCZhihui Chang
Zhihui Chang
JZJiahe Zheng
Jiahe Zheng
Background: The aim of the present study was to assess the feasibility of applying low-dose contrast media (CM), and to explore the optimal virtual monoenergetic images (VMIs) in run-off computed tomography (CT) angiography (CTA) on dual-layer spectral detector CT (SDCT). Methods: Forty patients were randomly assigned into a control group using routine volume CM (group A) and an experimental group using half-volume CM (group B). In groups A and B, 120 kVp polychromatic conventional images were generated via hybrid iterative reconstruction algorithm defined as A1 and B1, respectively. Additionally, in group B, VMIs (range, 40–120 keV) were reconstructed via a spectral reconstruction algorithm defined as B2–B10. Vascular attenuation, noise, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and radiation dose were evaluated. Subjective evaluation was performed using a 5-point scale. Results: The patient demographics and radiation dose demonstrated no significant difference between groups A and B [dose length product (DLP): 1,823.45±512.68 vs. 2,014.40±453.25 mGy·cm, P=0.229; volume CT dose index: 14.92±3.40 vs. 16.26±2.85 mGy, P=0.208; the effective dose (ED): 10.82±3.02 vs. 11.88±2.67 mSv, P=0.229]. The mean vascular attenuation was higher in group B2 (40 keV) and was lower in group B3 (50 keV) in comparison with that in group A1 (487.07±154.21 vs. 414.35±71.66 HU, 329.90±100.25 vs. 414.35±71.66 HU, P>0.05). Compared with group A1, the mean noise was similar in group B2 (40 keV) and was lower in group B1 and groups B3–B10 (50–120 keV) (14.81±5.67 vs. 17.29±4.70 HU, P>0.05; 6.75±1.23–11.26±3.24 vs. 17.29±4.70 HU, P<0.05). The mean SNR and CNR in group B2 (40 keV), as well as the mean SNR in group B3 (50 keV), were significantly higher than those of group A1 (38.21±7.52 vs. 28.25±7.20, 32.70±7.79 vs. 24.54±6.60, 32.85±7.10 vs. 28.25±7.20, P0.05). Scores of subjective image quality (IQ) in group B2 (40 keV) and B3 (50 keV) were similar to those in group A1 {5 [4.25, 5] vs. 5 [4, 5], 5 [5, 5] vs. 5 [4, 5], P>0.05}, and showed a declining trend in group B4 (60 keV) {4 [4, 5] vs. 5 [4, 5], P>0.05}. Conclusions: It is feasible to perform run-off CTA using low-dose CM with VMI on SDCT. The VMIs at 40–50 keV were the optimal choice and did not compromise IQ.

1 April 2022 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
YZYanhua Zhen
Yanhua Zhen
HRHaiyan Ren
Haiyan Ren
JCJie Chen
Jie Chen
ZCZhihui Chang
Zhihui Chang
CWChuanzhuo Wang
Chuanzhuo Wang
JZJiahe Zheng
Jiahe Zheng

11 July 2023 in Inflammation
Verified
Journal Article
Closed access
PDF file
ZXZeyu Xing
Zeyu Xing
YZYanhua Zhen
Yanhua Zhen
JCJie Chen
Jie Chen
MDMingyang Du
Mingyang Du
DLDongdong Li
Dongdong Li
JZJiahe Zheng
Jiahe Zheng